Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 2025-2031, June 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cabral, F.
Right arrow Articles by Yuspa, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cabral, F.
Right arrow Articles by Yuspa, S. H.

Induction of Specific Protein Synthesis by Phorbol Esters in Mouse Epidermal Cell Culture

Fernando Cabral1, Michael M. Gottesman and Stuart H. Yuspa2

Molecular Genetics Section, Laboratory of Molecular Biology [F. C., M. M. G.], and in Vitro Pathogenesis Section, Laboratory of Experimental Pathology [S. H. Y.], National Cancer Institute, Bethesda, Maryland 20205

The induction of specific protein synthesis by the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA), was studied in cultured mouse epidermal cells by two-dimensional gel electrophoresis after pulse-labeling with [35S]methionine. While overall protein synthesis was moderately inhibited by TPA, the synthesis of five specific proteins was increased. Three of these proteins (M.W. 25,000, M.W. 55,000, and M.W. 70,000) were either not synthesized or synthesized at low rates in untreated cells, while two proteins (M.W. 35,000 and M.W. 50,000) were also synthesized in controls but to a lesser extent than in TPA-treated cells. Increased synthesis of the M.W. 50,000 protein could be seen as early as 1 hr after TPA exposure, while maximum induction of all proteins was observed at 6 hr. By 24 hr, synthesis rates of these proteins had returned to near basal levels even if TPA exposure was continued. The amino acid analog canavanine (at levels which inhibited protein synthesis to the same extent as does TPA) or nonpromoting analogs of TPA did not induce these proteins. Pulse-chase studies indicated that these proteins were not degradation products which may have resulted from TPA exposure and that the M.W. 25,000 and M.W. 35,000 protein appear to be rapidly turned over. 32PO4 labeling indicated that only the M.W. 55,000 protein was significantly phosphorylated and that TPA did not induce a qualitative change in the pattern of phosphorylation of epidermal proteins. Definitive identification of these proteins has not been made, but the specific stimulation of their synthesis supports a model of tumor promoter action in which promoters induce a specific program of changes in macromolecular synthesis in the epidermis.

1 Present address: Division of Endocrinology, University of Texas Medical School, Houston, Texas.

2 To whom requests for reprints should be addressed.

Received 10/21/80. Accepted 2/19/81.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.